Lens-sparing vitrectomy effective for reattachment of newly developed falciform retinal detachment in a patient with norrie disease

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 579-580

  Kusaka, Shunji ^a   Shima, Chiharu ^b   Kondo, Hiroyuki ^b   Hasebe, Haruyuki ^b   Fujikado, Takashi ^b   Tano, Yasuo ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B SCAN; CASE REPORT; CLINICAL FEATURE; FLUORESCENCE ANGIOGRAPHY; GENETIC ANALYSIS; HUMAN; INFANT; LASER COAGULATION; LENSECTOMY; LETTER; MALE; MEDICAL INSTRUMENTATION; NORRIE DISEASE; PRIORITY JOURNAL; SCLEROTOME; SLIT LAMP; VITRECTOMY;

BLINDNESS; CHILD, PRESCHOOL; DEAFNESS; EYE PROTEINS; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MALE; MENTAL RETARDATION; NERVE TISSUE PROTEINS; RETINA; RETINAL DETACHMENT; VISUAL ACUITY; VITRECTOMY;

EID: 65249185761     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.35     Document Type: Letter

References (5)

1. Duvall-Young J, Short C, Raines M, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol. 1989;73(11):900-906.
2. Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593-599.
3. Green WR. Retina. Pathology of the macula. In: Spencer WH, ed. Ophthalmic Pathology: An Atlas and Textbook. 3rded. Philadelphia, PA: WB Saunders; 1985: 936-961.
4. Mullins RR, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15(pt 3):390-395.
5. Hassenstein A, Gisbert R. Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option: a case report [in German]. Klin Monatsbl Augenheilkd. 2003;220(7): 492-495.